Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
H Ebrahimi Shahmabadi, F Movahedi… - Tumor Biology, 2014 - Springer
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.
F Movahedi, SE Alavi, A Eslamifar… - Tumour Biology: the …, 2014 - europepmc.org
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
HE Shahmabadi, F Movahedi, MKM Esfahani, SE Alavi… - Tumor Biology, 2014 - infona.pl
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
[PDF][PDF] Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
HE Shahmabadi, F Movahedi, MKM Esfahani… - researchgate.net
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma Hasan
Ebrahimi Shahmabadi1, Fatemeh Mova Page 1 1 Efficacy of Cisplatin-loaded polybutyl …
Ebrahimi Shahmabadi1, Fatemeh Mova Page 1 1 Efficacy of Cisplatin-loaded polybutyl …
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
HE Shahmabadi, F Movahedi, MKM Esfahani… - Tumor …, 2014 - search.proquest.com
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
[引用][C] Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
H Ebrahimi Shahmabadi, F Movahedi… - Tumor …, 2014 - espace.library.uq.edu.au
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
HE Shahmabadi, F Movahedi… - … biology: the journal …, 2014 - pubmed.ncbi.nlm.nih.gov
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood-brain barrier (BBB). In this study, Cisplatin …